{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:17:41Z","timestamp":1783131461455,"version":"3.54.6"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018708","name":"Euratom Research and Training Programme","doi-asserted-by":"publisher","award":["945196"],"award-info":[{"award-number":["945196"]}],"id":[{"id":"10.13039\/100018708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejmp.2026.105811","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:43:45Z","timestamp":1777747425000},"page":"105811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Accounting for out-of-field dose and second cancer risk in classical Hodgkin lymphoma: A comprehensive comparison of proton and photon therapy using whole-body phantom"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2479-5430","authenticated-orcid":false,"given":"Mona","family":"Azizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-0280","authenticated-orcid":false,"given":"Maite","family":"Romero-Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-9738","authenticated-orcid":false,"given":"Forough","family":"Jafarian-Dehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidora S.","family":"Mu\u00f1oz-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7444-436X","authenticated-orcid":false,"given":"Ignacio N.","family":"L\u00f3pez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-4498","authenticated-orcid":false,"given":"Ignacio","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Norrlid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Goldkuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0713-3108","authenticated-orcid":false,"given":"Beatriz","family":"S\u00e1nchez-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Toma-Dasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Dasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2026.105811_b0005","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/0284186X.2023.2251089","article-title":"Multi-center comparison between proton and photon plans for mediastinal lymphomas","volume":"62","author":"Brincker","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0010","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin\u2019s disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0015","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1667\/RR0763.1","article-title":"Solid cancer incidence in atomic bomb survivors: 1958-1998","volume":"168","author":"Preston","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejmp.2026.105811_b0025","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1158\/0008-5472.CAN-10-0276","article-title":"Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejmp.2026.105811_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","article-title":"The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)","volume":"188","author":"Hodapp","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejmp.2026.105811_b0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmp.2017.10.004","article-title":"Risk of second cancer following radiotherapy","volume":"42","author":"Toma-Dasu","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0040","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200354","article-title":"Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma","volume":"94","author":"Timlin","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2026.105811_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmp.2020.06.012","article-title":"Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties","volume":"76","author":"Raptis","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0050","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejmp.2026.105811_b0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2010.05.035","article-title":"Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage Hodgkin lymphoma in female patients","volume":"81","author":"Weber","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","article-title":"Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk","volume":"92","author":"Filippi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","article-title":"Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma","volume":"84","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13014-020-1462-2","article-title":"Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with Hodgkin\u2019s lymphoma. Assessment of risk of toxicity and secondary cancer induction","volume":"15","author":"Scorsetti","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijrobp.2017.09.039","article-title":"Intensity modulated radiation therapy and second cancer risk in adults","volume":"100","author":"Filippi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rpd\/nct335","article-title":"Radiation burden from secondary doses to patients undergoing radiation therapy with photons and light ions and radiation doses from imaging modalities","volume":"161","author":"Gudowska","year":"2014","journal-title":"Radiat Prot Dosim"},{"key":"10.1016\/j.ejmp.2026.105811_b0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rpd\/ncy013","article-title":"Impact of irradiation setup in proton spot scanning brain therapy on organ doses from secondary radiation","volume":"180","author":"Ardenfors","year":"2018","journal-title":"Radiat Prot Dosim"},{"key":"10.1016\/j.ejmp.2026.105811_b0090","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1088\/0031-9155\/53\/13\/R01","article-title":"A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction","volume":"53","author":"Xu","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105811_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.104879","article-title":"Individualized evaluation of the total dose received by radiotherapy patients: integrating in-field, out-of-field, and imaging doses","volume":"129","author":"Romero-Exp\u00f3sito","year":"2025","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0100","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/cancers13153746","article-title":"Current situation of proton therapy for Hodgkin lymphoma: from expectations to evidence","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmp.2026.105811_b0105","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/cancers13153744","article-title":"Development and implementation of proton therapy for Hodgkin lymphoma: challenges and perspectives","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmp.2026.105811_b0110","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00066-014-0719-9","article-title":"Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?","volume":"190","author":"Lohr","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejmp.2026.105811_b0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0360-3016(97)00012-6","article-title":"Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy","volume":"38","author":"Followill","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0130","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/ijerph9114223","article-title":"Integral dose and radiation-induced secondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapy","volume":"9","author":"D\u2019Arienzo","year":"2012","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ejmp.2026.105811_b0135","series-title":"The Physics of Radiation Therapy","first-page":"429","author":"Khan","year":"2003"},{"key":"10.1016\/j.ejmp.2026.105811_b0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0145","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejmp.2026.105811_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103183","article-title":"IS2aR, a computational tool to transform voxelized reference phantoms into patient-specific whole-body virtual CTs for peripheral dose estimation","volume":"116","author":"Mu\u00f1oz-Hern\u00e1ndez","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0155","first-page":"1","article-title":"ICRP Publication 110. Realistic reference phantoms: an ICRP\/ICRU joint effort. a report of adult reference computational phantoms","volume":"39","author":"Menzel","year":"2009","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ejmp.2026.105811_b0160","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/j.ejmp.2026.105811_b0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/acm2.12367","article-title":"Estimating the uncertainty of calculated out-of-field organ dose from a commercial treatment planning system","volume":"19","author":"Wang","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.872752","article-title":"A simple analytical model for a fast 3D assessment of peripheral photon dose during coplanar isocentric photon radiotherapy","volume":"12","author":"S\u00e1nchez-Nieto","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0175","article-title":"Range shifter contribution to neutron exposure of patients undergoing proton pencil beam scanning","author":"Romero-Exp\u00f3sito","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmp.2018.08.020","article-title":"Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment","volume":"53","author":"Ardenfors","year":"2018","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0185","unstructured":"Werner CJ, et al. MCNP user\u2019s manual - code version 6.2. 2017."},{"key":"10.1016\/j.ejmp.2026.105811_b0190","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 2007;37(2\u20134):1\u2013332. https:\/\/doi.org\/10.1016\/j.icrp.2007.10.003.","DOI":"10.1016\/j.icrp.2007.10.003"},{"key":"10.1016\/j.ejmp.2026.105811_b0195","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1118\/1.4938578","article-title":"Experimental evaluation of neutron dose in radiotherapy patients: which dose?","volume":"43","author":"Romero-Exp\u00f3sito","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4682-8-27","article-title":"Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"8","author":"Schneider","year":"2011","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.ejmp.2026.105811_b0205","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aab469","article-title":"Dose distribution of secondary radiation in a water phantom for a proton pencil beam \u2013 EURADOS WG9 intercomparison exercise","volume":"63","author":"Stolarczyk","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105811_b0210","series-title":"Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2","author":"National Research Council","year":"2006"},{"key":"10.1016\/j.ejmp.2026.105811_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2025.105686","article-title":"Ionized variability across Monte Carlo codes in a proton therapy scenario","volume":"141","author":"Romero-Exp\u00f3sito","year":"2026","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0220","doi-asserted-by":"crossref","first-page":"N89","DOI":"10.1088\/0952-4746\/32\/1\/N89","article-title":"Cancer risk modelling and radiological protection","volume":"32","author":"Wakeford","year":"2012","journal-title":"J Radiol Prot"},{"key":"10.1016\/j.ejmp.2026.105811_b0225","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1002\/mp.12462","article-title":"AAPM TG 158: measurement and calculation of doses outside the treated volume from external-beam radiation therapy","volume":"44","author":"Kry","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","article-title":"Intensity-modulated radiation therapy, protons, and the risk of second cancers","volume":"65","author":"Hall","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0235","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0240","first-page":"811","article-title":"Cost-effectiveness of proton therapy compared with photon therapy in breast cancer","volume":"95","author":"Verma","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2025.105002","article-title":"Evaluation of secondary cancers risk induction in adjuvant breast radiotherapy: creation of technique independent dose\u2013effect curves for OARs dose optimization","volume":"134","author":"Moretti","year":"2025","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1667\/RR2737.1","article-title":"Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam","volume":"179","author":"Britten","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejmp.2026.105811_b0255","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1088\/0031-9155\/57\/21\/7117","article-title":"Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer","volume":"57","author":"Rechner","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105811_b0260","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190412","article-title":"Neutron dose and its measurement in proton therapy \u2013 current state of knowledge","volume":"93","author":"H\u00e4lg","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2026.105811_b0265","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2006.01.052","article-title":"Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or Stage III non-small-cell lung cancer","volume":"65","author":"Chang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0270","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab8ddc","article-title":"Body-size-dependent phantom library constructed from ICRP mesh-type reference computational phantoms","volume":"65","author":"Choi","year":"2020","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105811_b0275","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac4738","article-title":"A patient-specific hybrid phantom for calculating radiation dose and equivalent dose to the whole body","volume":"67","author":"Kollitz","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105811_b0280","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.zemedi.2021.05.001","article-title":"Development of whole-body representation and dose calculation in a commercial treatment planning system","volume":"32","author":"Hauri","year":"2022","journal-title":"Z Med Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0285","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0290","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2013.11.239","article-title":"Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses","volume":"88","author":"Sethi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0295","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190334","article-title":"Modelling variable proton relative biological effectiveness for treatment planning","volume":"93","author":"McNamara","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2026.105811_b0300","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0305","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0310","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1016\/j.clml.2020.03.006","article-title":"Long-term Hodgkin lymphoma survivors: a glimpse of what happens 10 years after treatment","volume":"20","author":"Laddaga","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ejmp.2026.105811_b0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","article-title":"Secondary breast cancer risk by radiation volume in women with Hodgkin lymphoma","volume":"97","author":"Conway","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0320","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-018-1066-2","article-title":"Proton versus photon deep inspiration breath hold technique in patients with Hodgkin lymphoma and mediastinal radiation: a planning comparison of deep inspiration breath hold intensity modulation radiotherapy and intensity modulated proton therapy","volume":"13","author":"Baues","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0325","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: a review of current literature and clinical use in practice","volume":"84","author":"Teoh","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2026.105811_b0330","doi-asserted-by":"crossref","unstructured":"van Leeuwen FE, Ng AK. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematology Am Soc Hematol Educ Program 2016;2016:323-30. (Note: adjusted for standard abbr.).","DOI":"10.1182\/asheducation-2016.1.323"},{"key":"10.1016\/j.ejmp.2026.105811_b0335","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantages of a \u201cbutterfly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin\u2019s lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0340","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2012.09.001","article-title":"Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship","volume":"86","author":"Berrington de Gonzalez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105811_b0345","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","article-title":"Lung cancer following chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"94","author":"Travis","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejmp.2026.105811_b0350","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.adro.2019.07.010","article-title":"Does the incidence of treatment-related toxicity plateau after radiation therapy: the long-term impact of integral dose in Hodgkin\u2019s lymphoma survivors","volume":"4","author":"Holtzman","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/0284186X.2018.1512153","article-title":"Comparative treatment planning study for mediastinal Hodgkin\u2019s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy","volume":"58","author":"Edvardsson","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0360","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-8140(99)00036-5","article-title":"A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy","volume":"51","author":"Lomax","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmp.2021.09.005","article-title":"Out-of-field organ doses and associated risk of cancer development following radiation therapy with photons","volume":"90","author":"Mazonakis","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105811_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.892078","article-title":"Determining out-of-field doses and second cancer risk from proton therapy in young patients - an overview","volume":"12","author":"Romero-Exp\u00f3sito","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0375","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1200\/JCO.2007.11.2003","article-title":"Long-term health status among survivors of childhood cancer: does sex matter?","volume":"25","author":"Armstrong","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0380","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1088\/0031-9155\/54\/16\/005","article-title":"Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy","volume":"54","author":"Athar","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105811_b0385","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/0284186X.2019.1639823","article-title":"Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation","volume":"58","author":"Toussaint","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2026.105811_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2026.105748","article-title":"Personalized organ dose assessment from CT imaging during proton therapy for classical Hodgkin lymphoma patients","volume":"143","author":"Gkavonatsiou","year":"2026","journal-title":"Phys Med"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:29:29Z","timestamp":1783128569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":78,"alternative-id":["S1120179726000980"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105811","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accounting for out-of-field dose and second cancer risk in classical Hodgkin lymphoma: A comprehensive comparison of proton and photon therapy using whole-body phantom","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105811"}}